These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 27789373)
1. Design of hydrogels of 5-hydroxymethyl tolterodine and their studies on pharmacokinetics, pharmacodynamics and transdermal mechanism. Liu W; Teng L; Yu K; Sun X; Fan C; Long C; Liu N; Li S; Wu B; Xu Q; Sun F; Li Y Eur J Pharm Sci; 2017 Jan; 96():530-541. PubMed ID: 27789373 [TBL] [Abstract][Full Text] [Related]
2. Preparation, characterization and pharmacological evaluation of tolterodine hydrogels for the treatment of overactive bladder. Sun F; Sui C; Zhou Y; Liu X; Shi Y; Wu Y; Li Y Int J Pharm; 2013 Sep; 454(1):532-8. PubMed ID: 23891744 [TBL] [Abstract][Full Text] [Related]
3. Design of transparent film-forming hydrogels of tolterodine and their effects on stratum corneum. Liu X; Fu L; Dai W; Liu W; Zhao J; Wu Y; Teng L; Sun F; Li Y Int J Pharm; 2014 Aug; 471(1-2):322-31. PubMed ID: 24882035 [TBL] [Abstract][Full Text] [Related]
4. Synergistic effect of iontophoresis and chemical enhancers on transdermal permeation of tolterodine tartrate for the treatment of overactive bladder. Prasanthi D; Lakshmi PK Int Braz J Urol; 2013; 39(1):63-75; discussion 76. PubMed ID: 23489517 [TBL] [Abstract][Full Text] [Related]
5. Comparison of pharmacokinetic variability of fesoterodine vs. tolterodine extended release in cytochrome P450 2D6 extensive and poor metabolizers. Malhotra B; Darsey E; Crownover P; Fang J; Glue P Br J Clin Pharmacol; 2011 Aug; 72(2):226-34. PubMed ID: 21352267 [TBL] [Abstract][Full Text] [Related]
6. Silicone adhesive, a better matrix for tolterodine patches-a research based on in vitro/in vivo studies. Liu J; Wang Z; Liu C; Xi H; Li C; Chen Y; Sun L; Mu L; Fang L Drug Dev Ind Pharm; 2012 Aug; 38(8):1008-14. PubMed ID: 22126709 [TBL] [Abstract][Full Text] [Related]
7. The design and development of fesoterodine as a prodrug of 5-hydroxymethyl tolterodine (5-HMT), the active metabolite of tolterodine. Malhotra B; Gandelman K; Sachse R; Wood N; Michel MC Curr Med Chem; 2009; 16(33):4481-9. PubMed ID: 19835561 [TBL] [Abstract][Full Text] [Related]
8. Muscarinic receptor binding of fesoterodine, 5-hydroxymethyl tolterodine, and tolterodine in rat tissues after the oral, intravenous, or intravesical administration. Yamada S; Kuraoka S; Ito Y; Kato Y; Onoue S J Pharmacol Sci; 2019 May; 140(1):73-78. PubMed ID: 31153768 [TBL] [Abstract][Full Text] [Related]
9. Studies on the preparation, characterization and pharmacological evaluation of tolterodine PLGA microspheres. Sun F; Sui C; Teng L; Liu X; Teng L; Meng Q; Li Y Int J Pharm; 2010 Sep; 397(1-2):44-9. PubMed ID: 20600717 [TBL] [Abstract][Full Text] [Related]
10. Transdermal delivery of tolterodine by O-acylmenthol: In vitro/in vivo correlation. Zhao L; Li Y; Fang L; He Z; Liu X; Wang L; Xu Y; Ren C Int J Pharm; 2009 Jun; 374(1-2):73-81. PubMed ID: 19446762 [TBL] [Abstract][Full Text] [Related]
11. Effect of enhancers and retarders on percutaneous absorption of flurbiprofen from hydrogels. Fang JY; Hwang TL; Leu YL Int J Pharm; 2003 Jan; 250(2):313-25. PubMed ID: 12527159 [TBL] [Abstract][Full Text] [Related]
12. Plasma concentration profile of tolterodine and 5-hydroxymethyl tolterodine following transdermal administration of tolterodine in rats. Seok Ji Y; Kim IS; Kim TK; Yoo HH Pharmazie; 2018 Jul; 73(7):375-378. PubMed ID: 30001770 [TBL] [Abstract][Full Text] [Related]
13. Utility of nanosized microemulsion for transdermal delivery of tolterodine tartrate: ex-vivo permeation and in-vivo pharmacokinetic studies. Elshafeey AH; Kamel AO; Fathallah MM Pharm Res; 2009 Nov; 26(11):2446-53. PubMed ID: 19697106 [TBL] [Abstract][Full Text] [Related]
14. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation. Yang Z; Teng Y; Wang H; Hou H Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of tolterodine, a muscarinic receptor antagonist, in mouse, rat and dog. Interspecies relationship comparing with human pharmacokinetics. Påhlman I; Kankaanranta S; Palmér L Arzneimittelforschung; 2001 Feb; 51(2):134-44. PubMed ID: 11258043 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic and Pharmacodynamics of Self-Assembled Cubic Liquid Crystalline Nanoparticle Gel After Transdermal Administration. Zhu N; Wu XX; Tian Y; Zhu JX; Li JC Med Sci Monit; 2018 Apr; 24():2330-2338. PubMed ID: 29666359 [TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetics of the 5-hydroxymethyl metabolite of tolterodine after administration of fesoterodine sustained release tablet in Western and East Asian populations. Oishi M; Tomono Y; Yamagami H; Malhotra B J Clin Pharmacol; 2014 Aug; 54(8):928-36. PubMed ID: 24619889 [TBL] [Abstract][Full Text] [Related]
18. Systemic enhancement of papaverine transdermal gel for erectile dysfunction. Wen MM; El-Kamel AH; Khalil SA Drug Dev Ind Pharm; 2012 Aug; 38(8):912-22. PubMed ID: 22080854 [TBL] [Abstract][Full Text] [Related]
19. Effect of permeation enhancers on transdermal delivery of fluoxetine: in vitro and in vivo evaluation. Jung E; Kang YP; Yoon IS; Kim JS; Kwon SW; Chung SJ; Shim CK; Kim DD Int J Pharm; 2013 Nov; 456(2):362-9. PubMed ID: 24012861 [TBL] [Abstract][Full Text] [Related]
20. Preparation of mixed monoterpenes edge activated PEGylated transfersomes to improve the in vivo transdermal delivery efficiency of sinomenine hydrochloride. Wang J; Wei Y; Fei YR; Fang L; Zheng HS; Mu CF; Li FZ; Zhang YS Int J Pharm; 2017 Nov; 533(1):266-274. PubMed ID: 28943208 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]